Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression

Published:2015-02-03 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zhang Xia,Zhang Bin,Liu Jie,Liu Jiwei,Li Changzheng,Dong Wei,Fang Shu,Li Minmin,Song Bao,Tang Bo,Wang Zhehai,Zhang Yang

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep07835.pdf

Reference43 articles.

1. Johnston, S. R. Acquired tamoxifen resistance in human breast cancer-potential mechanisms and clinical implications. Anticancer Drugs 8, 911–930 (1997).

2. Smith, R. A., Cokkinides, V. & Brooks, D. Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 61, 8–30 (2011).

3. Early Breast Cancer Trailist Collaborative Group. Tamoxifen for early breast cancer:an overview of the randomized trials. Lancet 351, 1451–1467 (1998).

4. Creighton, C. J. et al. Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts. Cancer Res 8, 7493–7501 (2008).

5. Harvey, J. M., Clark, G. M., Osborne, C. K. & Allred, D. C. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J ClinOncol 17, 1474–1481 (1999).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of covalently linked tamoxifen hybrids for cancer treatment: recent update;RSC Medicinal Chemistry;2024

2. Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells;Pharmaceuticals;2023-11-02

3. Mimicking 3D breast tumor-stromal interactions to screen novel cancer therapeutics;European Journal of Pharmaceutical Sciences;2023-11

4. Acupoint Thread Embedding Combined With Wenshen Bugu Decoction for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptom Among Postmenopausal Breast Cancer Patients: Study Protocol of a Randomized Controlled Trial;Integrative Cancer Therapies;2023-01

5. Therapeutic significance of molecular hybrids for breast cancer research and treatment;RSC Medicinal Chemistry;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3